MetaVia

MTVANasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$7.695 M

$1.49 +2.76%

Close of 7 Aug 2026

Revenue

—

Not reported

Earnings

-$13.0M

Loss-making

Shares outstanding

6,588,101

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#446CNS PharmaceuticalsCNSP$7.86M
#447Bolt BiotherapeuticsBOLT$7.78M
#448MetaViaMTVA$7.69M
#449BiovieBIVI$7.54M
#450Can-Fite BioPharmaCANF$7.37M

Where these numbers come from

Share counts and financials for MetaVia are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.